CFBK
CF Bankshares Inc.
CFBK has a slight edge over JPM overall, supported by stronger fundamentals and stronger modeled upside.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
CFBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CFBK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CFBK.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CFBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.8x | $16.50 | -53% |
| Fair | 7.7x | $26.58 | -25% |
| Forward | 8.7x | $35.32 | — |
| Current | 10x | $35.32 | — |
| Expensive | 11x | $37.27 | +5.5% |
Historical ranges are pointers, not guarantees.
CFBK's PE is in its expensive range at 10x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CFBK in the historical PE scenario, which offers more potential upside but is not a forecast.
CFBK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
CFBK has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CFBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.08 | +18% |
| Q3 2026 | $3.46 | +39% |
| Q2 2026 | $2.91 | +4.7% |
| Q1 2026 | $2.78 | +22% |
| Q4 2025 | $2.69 | +31% |
| Q3 2025 | $2.49 | +21% |
| Q2 2025 | $2.78 | +38% |
| Q1 2025 | $2.27 | -6.2% |
| Q4 2024 | $2.06 | -22% |
CFBK's earnings per share have fallen from their peak: $3.46 over the past year, against $5.13 in early 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CFBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.7M | +7.7% |
| Q2 2026 | $16.5M | +6.2% |
| Q1 2026 | $14.8M | +4.9% |
| Q4 2025 | $15.7M | +13% |
| Q3 2025 | $15.5M | +19% |
| Q2 2025 | $15.6M | +24% |
| Q1 2025 | $14.1M | +16% |
| Q4 2024 | $14M | +9.3% |
CFBK has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | +27 points |
| Q2 2026 | 44% | +2.8 points |
| Q1 2026 | 40% | +0.3 points |
| Q4 2025 | 43% | +6.5 points |
| Q3 2025 | 17% | -23 points |
| Q2 2025 | 41% | +26 points |
| Q1 2025 | 40% | +8.6 points |
| Q4 2024 | 37% | -3.5 points |
CFBK has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
CFBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.4M | +61% |
| Q2 2026 | $5M | -36% |
| Q1 2026 | $4.6M | +115% |
| Q4 2025 | $3M | -76% |
| Q3 2025 | $5.2M | +$6.5M |
| Q2 2025 | $7.8M | +97% |
| Q1 2025 | $2.2M | +$3.3M |
| Q4 2024 | $12.4M | +56% |
CFBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CFBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +112K shares |
| 1 year | +2% | +129K shares |
| 3 years | +0.3% | +18.9K shares |
| 5 years | -2.7% | -182K shares |
| Available history | +40% | +1.8M shares |
CFBK has 6M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150,000 |
| Q4 2025 | $440,000 |
| Q3 2025 | $76,000 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $44,000 |
| Q1 2024 | $179,000 |
| Q4 2022 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CFBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CFBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -8.4x | Net Cash |
| Q2 2026 | -10.3x | Net Cash |
| Q1 2026 | -11.3x | Net Cash |
| Q4 2025 | -11.1x | Net Cash |
| Q3 2025 | -12.7x | Net Cash |
| Q2 2025 | -11.4x | Net Cash |
| Q1 2025 | -12.3x | Net Cash |
| Q4 2024 | -13.3x | Net Cash |
CFBK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CFBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.7 | Neutral |
| Stochastic | 31.5 | Neutral |
CFBK's weekly RSI is 63 (neutral) and its Stochastic is 31 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CFBK PE vs Financial Services Sector
| Metric | CFBK | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 22% below |
| PE % | 75 | 63 | 12 pts above |
CFBK has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CFBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.4 | 2.7% above |
| 20 week MA | $34.4 | 2.7% above |
| 50 week MA | $30.9 | 14% above |
| 100 week MA | $27.2 | 30% above |
| 200 week MA | $23.5 | 51% above |
CFBK has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CFBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.1 | $18.0 | +28% |
| 2021 | $18.0 | $21.5 | +19% |
| 2022 | $21.5 | $21.4 | -0.4% |
| 2023 | $21.4 | $19.5 | -8.8% |
| 2024 | $19.5 | $23.9 | +23% |
| 2025 | $23.9 | $25.9 | +8.2% |
| 2026 YTD | $25.9 | $35.3 | +36% |
CFBK has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.